Absence of congenital prethrombotic disorders in children with Legg- Perthes disease

Journal of Pediatric Orthopaedics Part B

Volumn 9, Issue 1, 2000, Pages 24-27

  Sirvent, Nicolas ^a   Fisher, Florence ^b   El Hayek, Toni ^a   Appert, Annie ^b   Giudicelli, Henri ^c   Griffet, Jacques ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b University of Côte d'Azur   (France)

^c HÔPITAL DU BOCAGE   (France)

Author keywords

Activated protein C resistance; Legg Perthes disease; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ANTITHROMBIN III DEFICIENCY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; INFANT; MALE; PERTHES DISEASE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA;

EID: 0033971332     PISSN: 1060152X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01202412-200001000-00005     Document Type: Article

References (18)

1. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992;80:1998-2005.
2. Bertina RM, Koeleman B, Koster T, Rosendaal F, Vandenbroucke JP. Resistance to activated protein C and Factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995;74:449-53.
3. Brandt G, Gruppo R, Glueck CJ, et al. Sensitivity, specificity and predictive value of modified assays for activated protein C resistance in children. Thromb Haemost 1998;79:567-70.
4. Broekmans A, van Der Linden I, Veltkamp J, Bertina R. Prevalence of isolated protein C deficiency in patients with venous thrombotic disease and in the population [abstract]. Thromb Haemost 1983;50:350.
5. Caterall A. The natural history of Perthes' disease. J Bone Joint Surg Br 1971;53:37-53.
6. Choi D, Lee D, Chung C, Rhyu K, Park S. Changes in coagulation-fibrinolysis system in Legg-Perthes disease: a preliminary report [abstract]. Proc Pediatr Orthop Soc North Am 1995;2:1.
7. Dahlbäck B, Carlsonn M, Svensson P. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a co-factor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-8.
8. Dahlbäck B. Physiological anticoagulation: RPCA and venous thromboembolism. J Clin Invest 1994;94:923-7.
9. Glueck CJ, Glueck HI, Greenfield D, et al. Protein C and S deficiency, thrombophilia and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease. Pediatr Res 1994;35:383-8.
10. Glueck CJ, Crawford A, Roy D, Freiberg R, Glueck H, Stroop D. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg Am 1996;78:3-13.
11. Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop 1997;334:43-56.
12. Glueck CJ, Brandt G, Gruppo R, et al. Resistance to activated protein C and Legg-Perthes disease. Clin Orthop 1997;338:139-52.
13. Groupe d'étude de l'hémostase et de la thrombose (GEHT). Examens d'hémostase chez le malade qui a un antécédent thrombotique ou suspect de thrombose. Sang Thrombose Vaisseaux 1993;5(suppl)3:26-37.
14. Gruppo R, Glueck CJ, Wall E, Roy D, Wang P. Legg-Perthes disease in three siblings, two heterozygous for the factor V Leiden mutation. J Pediatr 1998;132:885-8.
15. McKee P. Disorders of blood coagulation. In: Wyngaarden JB, Smith LH, eds. Cecil textbook of medicine. Vol. 1. Philadelphia: Saunders, 1985:1040-58.
16. Rees DC. The population genetics of factor V Leiden (Arg506Gln). Br J Haematol 1996;95:579-86.
17. Tait R, Walker I, Reitsma P, et al. Prevalence of antithrombin III deficiency in the healthy population. Thromb Haemost 1995;73:87.
18. Suramo I, Puranen J, Heikkinen E, Vuorinen P. Disturbed patterns of venous drainage of the femoral neck in Perthes' disease. J Bone Joint Surg Br 1974;56:448-53.